2025-09-19 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data provided, formatted for a concise report.

## Albemarle Corp (ALB) Stock Analysis

**Company Overview:** Albemarle Corp is a global specialty chemicals company with leading positions in lithium, bromine, and refining catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** 24.09%
*   **VOO Cumulative Return:** 106.00%
*   **Absolute Divergence:** -82.7 (ALB significantly underperformed VOO)
*   **Relative Divergence:** 1.9 (ALB's underperformance is near the lowest end of its historical divergence range). This indicates a potential buying opportunity if you believe in the long-term prospects of the company and the sector.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha    | Beta   | Cap(B) |
|------------|--------|--------|----------|--------|--------|
| 2015-2017  | 99.0%  | 8.1%   | 70.0%    | 0.0    | 15.1   |
| 2016-2018  | 13.0%  | 58.0%  | -5.0%    | 0.0    | 9.1    |
| 2017-2019  | -44.0% | 58.0%  | -74.0%   | -0.0   | 8.6    |
| 2018-2020  | 101.0% | 62.9%  | 81.0%    | 0.6    | 17.4   |
| 2019-2021  | 268.0% | 62.9%  | 220.0%   | 0.6    | 27.5   |
| 2020-2022  | 239.0% | 75.6%  | 237.0%   | 0.8    | 25.5   |
| 2021-2023  | -53.0% | 77.5%  | -71.0%   | 0.6    | 17.0   |
| 2022-2024  | -200.0%| 77.5%  | -225.0%  | 0.7    | 10.1   |
| 2023-2025  | -324.0%| 77.5%  | -382.0%  | 2.9    | 9.5    |

**Analysis:**  The provided Alpha and Beta data paint a mixed picture. While there were periods of significant outperformance (high positive Alpha), recent years show substantial underperformance relative to the market (large negative Alpha). The Beta values are generally low, suggesting ALB hasn't been highly correlated with the overall market. However, the Beta value has been increasing recently, indicating that ALB is becoming more sensitive to market movements. The CAGR and MDD figures show the stock's volatile nature.

### 2. Recent Price Action

*   **Current Price:** 80.93
*   **Previous Close:** 80.16
*   **Change:** 0.96
*   **5-day Moving Average:** 79.81
*   **20-day Moving Average:** 80.19
*   **60-day Moving Average:** 75.40

**Analysis:** The stock is trading above its 5-day and 20-day moving averages, suggesting a short-term upward trend. The price is also significantly above its 60-day moving average, indicating a longer-term positive trend, although the shorter-term trends are more relevant right now. The recent price increase suggests some positive momentum.

### 3. Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 42.85 (Neutral - not overbought or oversold)
*   **PPO:** -0.22 (Slightly bearish, indicating the short-term moving average is below the long-term moving average)
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.34) (Cash Ratio: 70% on 2025-09-16) - This signal suggests a cautious approach, recommending a high cash position and a slight reduction in holdings.
*   **Recent (20-day) Relative Divergence Change:** -1.3 (Short-term decrease)
*   **Expected Return (%):** 5361.9 - This exceptionally high projected return suggests significant potential upside relative to the S&P 500 over the long term, assuming a buy-and-hold strategy. However, use caution: this could be based on specific models and assumptions that may not hold true.

**Analysis:** The MRI indicates low market risk currently. The RSI is neutral. The PPO hints at slight bearishness. The Hybrid Signal is the most actionable, suggesting a defensive posture.  The negative change in relative divergence aligns with the underperformance noted earlier. The high expected return is noteworthy but should be carefully considered. The price has recently changed(0.96).

### 4. News & Events

*   **Recent News:**
    *   Articles discuss Albemarle's valuation in light of lithium price weakness.
    *   Recognition as a top-performing S&P 500 stock in August.
    *   Industry outlook highlighting Albemarle alongside DuPont and Methanex.
    *   Albemarle outperforming the broader market.
    *   Surge driven by earnings beat, cost cuts, and price target increases.
    *   Coverage within the context of diversified chemical stocks.
*   **Analyst Opinions:**
    *   Consensus: Hold
    *   Mean Target Price: 85.97 (suggests potential upside from current price)
    *   Recent Rating Changes: No changes were provided

**Analysis:** Recent news is mixed, with articles focusing on both potential value and positive performance. The analyst consensus is "Hold," with a target price that is slightly higher than the current price. This suggests analysts are cautiously optimistic about the stock.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue  |
|------------|-------|----------|
| 2025-08-04 | -0.16 | 1.33 B$  |
| 2025-04-30 | 0     | 1.08 B$  |
| 2024-11-06 | -9.45 | 1.35 B$  |
| 2024-07-31 | -1.96 | 1.43 B$  |
| 2025-08-04 | -1.96 | 1.43 B$  |

**Analysis:** Recent earnings have been inconsistent. While revenue has generally remained above $1 billion, EPS has fluctuated and been negative in several quarters.

### 6. Financial Information

| Quarter    | Revenue | Profit Margin | Equity    | ROE      |
|------------|---------|---------------|-----------|----------|
| 2025-06-30 | $1.33B  | 14.80%        | $10.24B   | 0.22%    |
| 2025-03-31 | $1.08B  | 14.51%        | $10.03B   | 0.41%    |
| 2024-12-31 | $1.23B  | 11.22%        | $9.96B    | 0.76%    |
| 2024-09-30 | $1.35B  | -7.68%        | $10.24B   | -10.44%  |
| 2024-06-30 | $1.43B  | -0.74%        | $11.22B   | -1.68%   |

**Analysis:** Revenue has fluctuated over the past year.  Profit margins have been inconsistent, with negative margins in some quarters. Equity has remained relatively stable. ROE has been very low and negative in some periods. This points to some difficulties in turning equity into profit.

### 7. Overall Assessment

Albemarle (ALB) presents a mixed investment picture.  It has significantly underperformed the S&P 500 recently. Recent news highlights both positive catalysts (earnings beat, analyst upgrades) and potential headwinds (lithium price weakness). Analyst ratings are neutral. Financial performance shows inconsistent earnings and profit margins.

**Key Considerations:**

*   **Lithium Market:**  ALB's performance is heavily tied to the lithium market. Monitor lithium prices and industry trends.
*   **Financial Performance:** Focus on the company's ability to improve profitability and revenue growth.
*   **Risk Tolerance:** The stock has demonstrated high volatility.

**Recommendation:** Given the mixed signals and recent underperformance, a cautious approach is warranted.  Consider the high cash position suggested by the Hybrid Signal. Any investment decision should be based on thorough research and an understanding of your own risk tolerance. If you believe in the long-term growth of the lithium market and ALB's position within it, the current price may represent a potential entry point, but be prepared for potential volatility.
